ACCA · Question 08 · Financial Reporting
Section A
BioMeat R&D Co develops lab-grown proteins. During the year ended 31 December 20X8, the company capitalized development costs of $800,000. For tax purposes, development costs are fully deductible in the year they are incurred. The company's tax rate is 25%. At 1 January 20X8, the deferred tax liability balance was $150,000. The carrying amount of the capitalized development costs at 31 December 20X8, after amortization, is $720,000.
What is the deferred tax charge or credit to the statement of profit or loss for the year ended 31 December 20X8?
Answer options:
Credit of $30,000
Charge of $180,000
Charge of $30,000
Credit of $150,000
32 questions · hints · full answers · grading